Mesenchymal Cell News Volume 2.32 | Aug 17 2010

    0
    20



    TOP STORY

    Researchers Discover that One Type of Stem Cell Creates a Niche for Another Type Within Bone Marrow  ShareThis
    Collaborators reported that the hematopoietic stem cells (HSCs) retain their unique features in response to signals from another stem cell population, the mesenchymal stem cells, which creates a supportive bone marrow niche for the HSCs. [Press release from Cold Spring Harbor Laboratory discussing online prepublication in Nature]

    MesenCult®-XF Medium 
    Culture Human Mesenchymal Stem Cells in
    Serum-Free MesenCult®-XF

    by STEMCELL Technologies
     
     
    WATCH THE WEBINARSTEMCELL Technologies Inc
     




    SCIENCE NEWS

    Mayo’s “Smart” Adult Stem Cells Repair Hearts
    Mayo Clinic investigators, with Belgian collaborators, have demonstrated that rationally “guided” human adult stem cells can effectively heal, repair and regenerate damaged heart tissue. [Press release from Mayo Clinic discussing online prepublication in the Journal of the American College of Cardiology]

    Aldefluor_645x110_v01




    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Mesenchymal and Hematopoietic Stem Cells Form a Unique Bone Marrow Niche
    Here researchers demonstrated that mesenchymal stem cells, identified using nestin expression, constitute an essential hematopoietic stem cells niche component. [Nature]

    Guided Cardiopoiesis Enhances Therapeutic Benefit of Bone Marrow Human Mesenchymal Stem Cells in Chronic Myocardial Infarction
    The goal of this study was to guide bone marrow-derived human mesenchymal stem cells into a cardiac progenitor phenotype and assess therapeutic benefit in chronic myocardial infarction. [J Am Coll Cardiol]

    Bone Marrow-Derived Mesenchymal Cells and MMP13 Contribute to Experimental Choroidal Neovascularization
    In this study, investigators evaluated the potential involvement of collagenase-3 (MMP13), a matrix metalloproteinase family member, in the exudative form of age-related macular degeneration characterized by a neovascularisation into the choroid. [Cell Mol Life Sci]

    Down-Regulation of Thrombomodulin, a Novel Target of Snail, Induces Tumorigenesis Through Epithelial-Mesenchymal Transition
    The expression of thrombomodulin (TM), a calcium-dependent adhesion molecule, is frequently down-regulated in various cancer types. However, the mechanism responsible for the low expression level of TM in tumorigenesis is unknown. Here, an inverse expression of TM and Snail was detected in different cancer cell lines. [Mol Cell Biol]

    Ultraviolet A Regulates Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Via Upregulation of Kruppel-Like Factor 2
    This study shows that ultraviolet A inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells and its action mechanisms. [J Biol Chem]

    Effects of Microgravity Modeled by Large Gradient High Magnetic Field on the Osteogenic Initiation of Human Mesenchymal Stem Cells
    In the present study, scientists used large gradient high magnetic field (LGHMF) produced by a superconducting magnet to model microgravity (LGHMF-MG) and analyzed the effects of LGHMF-MG on survival, cytoskeleton and osteogenic potential of human mesenchymal stem cells. [Stem Cell Rev]

    Isolation of Cancer Stem Cells from Transformed Human Mesenchymal Stem Cell Line F6
    In the present study, scientists isolated cancer stem cells from F6 cells based on CD133 expression using flow cytometry and investigated the biological characteristics of CD133+ F6 cells. [J Mol Med]

    Culture and Differentiation of Osteoblasts on Coral Scaffold from Human Bone Marrow Mesenchymal Stem Cells
    In this paper investigators described an approach that aims to provide fundamental information towards a scientific, biomechanical basis for the use of natural coral scaffolds to initiate mesenchymal stem cells into osteogenic differentiation for transplant purposes. [Cell Tissue Bank]




    INDUSTRY NEWS

    Mesoblast On Track For Phase 3 Bone Marrow Transplant Trial Following Positive Meeting With FDA
    Mesoblast Limited provided market guidance on its Phase 3 bone marrow transplant program following a formal meeting with the United States Food and Drug Administration (FDA). [Mesoblast Limited Press Release]

    Cytori Issued Celution(R) System Patent for Orthopedic & Spinal Disc Diseases
    Cytori Therapeutics has received U.S. Patent No. 7,771,716 (the ‘716 patent) for Celution(R) System based methods of treating musculoskeletal disorders such as spinal disc disease. [Cytori Therapeutics Press Release]

    NeoStem Provides Second Quarter Update
    NeoStem Inc. is providing results of its second quarter 2010. [NeoStem Inc. Press Release]

    Cardio3 BioSciences Publishes the Science Basis for C-Cure(R) in JACC
    Cardio3 BioSciences, a leading Belgian biotechnology company specializing in regenerative therapies for the treatment of cardiovascular disease, announced the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published. [Cardio3 Biosciences Press Release]




    POLICY NEWS

    EU Agency Allows Access to Drug Side Effects Data
    The European Medicines Agency has agreed to provide access to studies about drug side effects, following criticism over data secrecy from the European Ombudsman. [European Medicines Agency, European Union]

    Scientists Receive Nearly $11 Million to Develop Radiation Countermeasures
    Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome – part of acute radiation syndrome – for military personnel, first responders and the general public. [National Institute of Allergy and Infectious Diseases, United States]

    Proposed Collection; Comment Request; NIH NCI Central Institutional Review Board (CIRB) Initiative (NCI) (FR Doc. 2010-20167) [National Institutes of Health, United States]

    Center for Scientific Review, Notice of Closed Meetings (FR Doc. 2010- 20023) [National Institutes of Health, United States]

    National Center for Research Resources; Notice of Meeting (FR Doc. 2010-20014) [National Institutes of Health, United States]

    7342.007 Addendum – Imported Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)  [Center for Biologics Evaluation and Research, United States]

    7342.007 – Imported CBER-Regulated Products [Center for Biologics Evaluation and Research, United States]

    Complete List of Licensed Products and Establishments [Center for Biologics Evaluation and Research, United States]

    Comprehensive List of Guidance Documents at the Food and Drug Administration [Docket No. FDA-1998-N-0050] (formerly Docket No. 1998N-0046) [Food and Drug Administration, United States




    EVENTS (Listed by Date)

    Select Biosciences 3rd Annual Stem Cells Europe Conference
    August 24-25, 2010
    Edinburgh, Scotland

    Select Biosciences Inaugural Cellular Therapy Summit
    August 24-25, 2010
    Edinburgh, Scotland


    International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
    September 11-14, 2010
    Belgirate, Italy

    Hydra VI: The European Summer School on Stem Cells & Regenerative Medicine
    September 11-17, 2010
    Hydra, Greece

    Stem Cells USA & Regenerative Medicine Congress 2010
    September 13-15, 2010
    Philadelphia, United States   

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
    September 15-17, 2010
    Sydney, Australia

    5th Annual Germany Society for Stem Cell Research
    September 30-October 2, 2010
    Lübeck, Germany

    2010 World Stem Cell Summit
    October 4-6, 2010
    Detroit, United States

    5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010
    October 5-7, 2010
    Hannover, Germany

    17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.)
    October 6-9, 2010
    Munich, Germany

    bone-tec 2010 – International Bone-Tissue Engineering Congress
    October 7-10, 2010
    Hannover, Germany

    NEW The NYSCF Fifth Annual Translational Stem Cell Research Conference
    October 12-13, 2010
    New York, United States

    International Federation of Adipose Therapeutics & Science (IFATS) 2010 Conference
    October 22-24, 2010
    Dallas, United States

    2010 American Society for Matrix Biology (ASMB) Meeting
    October 24-27, 2010
    Charleston, United States

    Stem Cell Society Singapore Symposium 2010
    November 2-3, 2010
    Singapore

    52nd American Society of Hematology (ASH) Annual Meeting and Exposition
    December 4-7, 2010
    Orlando, United States

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
    December 5-8, 2010
    Orlando, United States

    Epithelial Plasticity and Epithelial to Mesenchymal Transition (A8)
    January 21-26, 2011
    Vancouver, Canada

    Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
    January 24-26, 2011
    Washington DC, United States

    NEW Stem Cells in Development, Tissue Homeostasis and Disease
    January 30-February 4, 2011
    Santa Fe, United States

    Stem Cells, Cancer and Metastasis (C4)
    March 6-11, 2011
    Keystone, United States

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



    JOB OPPORTUNITIES


    Cell Therapy Technologist (Opexa Therapeutics)

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News.
    Visit here to post your career opportunities.



    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    forwardafriendicon

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.